Citation Impact
2 by Nobel laureates 1 from Science/Nature 66 standout
Citing Papers
NF-κB in biology and targeted therapy: new insights and translational implications
2024 Standout
Multiple myeloma
2024 Standout
Works of Franck Dubin being referenced
Updates from ICARIA-MM, a phase 3 study of isatuximab (Isa) plus pomalidomide and low-dose dexamethasone (Pd) versus Pd in relapsed and refractory multiple myeloma (RRMM).
2021
A phase 1b study of isatuximab plus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma
2019
Author Peers
| Author | Hematology | Oncology | Molecular Biology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| Franck Dubin | 187 | 174 | 113 | 18 | 246 | |
| Inger M. Olsen | 33 | 38 | 225 | 10 | 486 | |
| Sarah Bird | 113 | 125 | 103 | 19 | 237 | |
| Rudy Fenwick | 2 | 18 | 887 | |||
| R. A. Swaters | 2 | 29 | 1.5k | |||
| Lucio Cattalini | 3 | 911 | 142 | 116 | 1.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...